WUXI BIOLOGICS (CAYMAN) INC. · 药明生物
Last · HKSEHK$49.12-2.13 (-4.16%)close · yahoo · 6h ago
Market capHK$202.2B4.12B sh
P/E · TTM38.1fwd 22.5 · eps 1.29
Beta0.59vs S&P 500
Div yield0.00%annual · TTM
52w range
HK$28.48HK$58.00
Volume410.8Ksession
| Revenue | ¥23.6B |
|---|---|
| Operating income | ¥7.5B |
| Net income | ¥6.5B |
| Free cash flow | ¥1.5B |
| Operating margin | 31.5% |
| Net margin | 27.7% |
| Return on equity | 13.6% |
| Period | TTM 2026-09-22 |
Loading chart…
Earnings transcripts
Documents
FormReporting forFiledFlags